Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress

Am J Pathol. 2005 Jun;166(6):1681-90. doi: 10.1016/S0002-9440(10)62478-9.

Abstract

Alcoholic liver disease is associated with zinc decrease in the liver. Therefore, we examined whether dietary zinc supplementation could provide protection from alcoholic liver injury. Metallothionein-knockout and wild-type 129/Sv mice were pair-fed an ethanol-containing liquid diet for 12 weeks, and the effects of zinc supplementation on ethanol-induced liver injury were analyzed. Zinc supplementation attenuated ethanol-induced hepatic zinc depletion and liver injury as measured by histopathological and ultrastructural changes, serum alanine transferase activity, and hepatic tumor necrosis factor-alpha in both metallothionein-knockout and wild-type mice, indicating a metallothionein-independent zinc protection. Zinc supplementation inhibited accumulation of reactive oxygen species, as indicated by dihydroethidium fluorescence, and the consequent oxidative damage, as assessed by immunohistochemical detection of 4-hydroxynonenal and nitrotyrosine and quantitative analysis of malondialdehyde and protein carbonyl in the liver. Zinc supplementation suppressed ethanol-elevated cytochrome P450 2E1 activity but increased the activity of alcohol dehydrogenase in the liver, without affecting the rate of blood ethanol elimination. Zinc supplementation also prevented ethanol-induced decreases in glutathione concentration and glutathione peroxidase activity and increased glutathione reductase activity in the liver. In conclusion, zinc supplementation prevents alcoholic liver injury in an metallothionein-independent manner by inhibiting the generation of reactive oxygen species (P450 2E1) and enhancing the activity of antioxidant pathways.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Central Nervous System Depressants / toxicity
  • Cytochrome P-450 CYP2E1 / drug effects
  • Dietary Supplements*
  • Ethanol / toxicity
  • Glutathione / drug effects
  • Glutathione Peroxidase / drug effects
  • Glutathione Reductase / drug effects
  • Liver / drug effects
  • Liver Diseases, Alcoholic / drug therapy*
  • Metallothionein / deficiency
  • Metallothionein / genetics
  • Mice
  • Mice, Knockout
  • Oxidative Stress / drug effects*
  • Zinc / therapeutic use*

Substances

  • Central Nervous System Depressants
  • Ethanol
  • Metallothionein
  • Glutathione Peroxidase
  • Cytochrome P-450 CYP2E1
  • Glutathione Reductase
  • Glutathione
  • Zinc